Skip to content
OpenCapital
Get started

TG Therapeutics TGTX Royalty — Revenue

Discontinued — last reported Q2 '25

Other product segments

License
$3.61M+201%

Similar metrics at other companies

Axsome Therapeutics logo
AXSMRoyalty — Revenue
$4.07M+269%
Alkermes logo
ALKSRoyalty — Revenue
$50.73M+13.5%
TEC
TECHRoyalty — Revenue
$4.97M-1.4%
BridgeBio Pharma logo
BBIORoyalty Revenue — Revenue
$1.62M—
Halozyme Therapeutics logo
HALORoyalties — Revenue from Contract with Customer, Excluding Assessed Tax
$240.68M+43.1%
Jazz Pharmaceuticals logo
JAZZOther royalty and contract revenues — Revenue from Contract with Customer, Excluding Assessed Tax
$7.3M-23.2%

Other financials

Income statement

See full
Revenue$204.9M+69.6%
Gross profit$171.4M+62.8%
Operating income$34.8M+304%
Net income$19.8M+291%
EPS (diluted)$0.12+300%

Balance sheet

See full
Cash & equivalents$442.2M+235%
Total debt$753.6M+197%
Total equity$583.1M+146%
Total assets$1.5B+133%

Cash flow

See full
Operating cash flow-$17.9M+37.7%
CapEx$51.0K+104%
Free cash flow-$17.9M+37.6%

Valuation

See full
Market cap$8.15B-14.3%
Enterprise value$8.46B-11.1%
P/E17.6×-225×
P/S11.6×-13.0×

Profitability

See full
Gross margin83.1%-4.4pp
Operating margin21.3%+5.9pp
Net margin66%+55.8pp
FCF margin-6,328.4%+4,773pp

Returns & leverage

See full
Return on equity112.6%+92.9pp
Debt / equity1.3×+0.2×
Current ratio5.8×+1.8×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: TG Therapeutics’s 10-Q, filed August 8, 2025, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's royalty — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TG Therapeutics's royalty — revenue?
TG Therapeutics (TGTX) reported royalty — revenue of $1.1M in Q2 2025.
How has TG Therapeutics's royalty — revenue changed year-over-year?
TG Therapeutics's royalty — revenue decreased by 35.3% year-over-year, from $1.7M to $1.1M.
What does royalty — revenue mean?
The net income earned from royalty agreements after excluding any associated sales taxes.
How do you interpret royalty — revenue?
An increase indicates growing commercial adoption or market penetration of the licensed products, while a decrease may signal declining market demand or the expiration of royalty-bearing rights.
How does royalty — revenue compare across companies?
Comparable to royalty revenue streams reported by other biopharmaceutical companies that license their drug candidates to third-party distributors or partners.